Live Breaking News & Updates on Respirerx Pharmaceuticals

Stay updated with breaking news from Respirerx pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RespireRX Pharmaceuticals makes key part time hire to drive business

RespireRx Pharmaceuticals (OTC:RSPI) has announced an agreement with Ponto Ventures LLC under which Will Clodfelter will serve as its senior vice president. ....

United States , Medicus Biosciences , Jeff Margolis , Eli Lilly , Ponto Ventures , Resolutionrx Ltd , Respirerx Pharmaceuticals , Respirerx Group , Amylin Pharmaceuticals , Will Clodfelter ,

RespireRx Pharmaceuticals : SETTLEMENT AND EXCHANGE AGREEMENT - Form 8-K -October 02, 2023 at 10:24 am EDT

SETTLEMENT AND EXCHANGE AGREEMENT

AGREEMENT made this 26th day of September 2023 by and between DNA Healthlink, Inc. and RespireRx Pharmaceuticals Inc. . DNA Healthlink and. ....

Jeff Eliot Margolis , Richardd Purcell , Respirerx Pharmaceutical Inc , Respirerx Pharmaceuticals Inc , Healthlink Inc , Td Bank , Exchange Agreement , Exchange Agreement Settlement , Respirerx Pharmaceuticals , Settlement Agreement , Prior Settlement Agreement , Three Hundred , Ninety Four Thousand , Redeemable Preferred Stock , Eligible Payment Event , Seriesi Preferred Stock , New Jersey , Jeff Eliot ,

Attention Deficit Hyperactivity Disorder Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)

DelveInsight s, Attention Deficit Hyperactivity Disorder Pipeline Insight 2023 report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Attention Deficit Hyperactivity. ....

United States , Yash Bhardwaj , Ensysce Biosciences , Las Vegas , Respirerx Pharmaceuticals , Arbor Pharmaceuticals , Delveinsight Business Research , Nz Pharmaceuticals , Otsuka Pharmaceutical Development Commercialization Inc , Company Name Drug , Biolite Inc , Deficit Hyperactivity Disorder Pipeline Insight , Attention Deficit Hyperactivity Disorder , Attention Deficit Hyperactivity Disorder Market , Cingulate Therapeutics , Pharmaceutical Development , Attention Deficit Hyperactivity Disorder Pipeline , Deficit Hyperactivity Disorder , Discovery Stage , Product Type , Clinical Stages , Attention Deficit Hyperactivity , Analytical Perspective , Late Stage Products , Mid Stage Products , Discovery Stage Products ,

Pharmaceutical cannabis sales and clinical trials surge, with broader disease focus

The global pharmaceutical cannabis market is poised for significant growth, projected to swell by 23% by 2027, mostly from one company but with other. ....

United Kingdom , Lawrence Purkiss , Zynerba Pharmaceuticals Inc , Oxford Cannabinoid Technologies Holdings , Corbus Pharmaceutical Holdings , Cannabics Pharmaceuticals Inc , Avicanna Inc , Kanabo Group , Ananda Developments Plc , Respirerx Pharmaceuticals , Jazz Pharmaceuticals , Prohibition Partners , Partners Pharmaceutical Cannabis , Developments Plc , Fast Track , Orphan Drug , Rare Pediatric Disease ,

Pharmaceutical cannabis sales surge, clinical trials seeing broader disease focus

The global pharmaceutical cannabis market is poised for significant growth, projected to swell by 23% by 2027, mostly from one company but with other. ....

United Kingdom , Zynerba Pharmaceuticals Inc , Oxford Cannabinoid Technologies Holdings , Respirerx Pharmaceuticals , Kanabo Group , Ananda Developments Plc , Cannabics Pharmaceuticals Inc , Corbus Pharmaceutical Holdings , Avicanna Inc , Jazz Pharmaceuticals , Prohibition Partners , Partners Pharmaceutical Cannabis , Developments Plc , Fast Track , Orphan Drug , Rare Pediatric Disease ,